Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Docetaxel & Non-small-cell lung cancer (NSCLC), Docetaxel is approved by both the FDA and the EMA for the treatment of Non-small-cell lung cancer (NSCLC), including Non-small-cell lung cancer (NSCLC) (Squamous Cell Carcinoma), either as monotherapy after prior chemotherapy failure or in combination with cisplatin for advanced cases (1, 2).
A comprehensive review of seven randomized controlled phase III clinical trials, encompassi…